Clinical trial
Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)
NCT00289874 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00289874 |
|---|---|
| Title | Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED) |
| Official title | A Multicenter, Double-Blind, Placebo Controlled, Randomized, Parallel-Group Study to Evaluate the Clinical Effect of Oral Montelukast Versus Placebo in Persistent Asthma Which is Also Active During Allergy Seasons in Pediatric Patients With Seasonal Aeroallergen Sensitivity |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | montelukast sodium, Comparator: Placebo |
| Enrollment | 421 |
| Start date | Mar 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Feb 10, 2006 |
| Last update posted | Feb 2, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: